|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/28 | (2015.01) |
| A61K 31/192 | (2013.01) | ||
| C12N 5/0789 | (2010.01) | ||
| A61K 35/28 | (2013.01) | ||
| A61P 9/00 | (2006.01) | ||
| C12N 5/0663 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| C12N2501/02 | (2013.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/14 | (2018.01) |
| (11) | Number of the document | 3534917 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17808627.8 |
| Date of filing the European patent application | 2017-10-23 | |
| (97) | Date of publication of the European application | 2019-09-11 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/057863 |
| Date | 2017-10-23 |
| (87) | Number | WO 2018/080990 |
| Date | 2018-05-03 |
| (30) | Number | Date | Country code |
| 201662411950 P | 2016-10-24 | US |
| (72) |
ILAGAN, Roger Marquez , US
HOGAN, Sarah , US
CHEADLE, John B. , US
|
| (73) |
United Therapeutics Corporation ,
1040 Spring Street, Silver Spring, MD 20910,
US
|
| (54) | ENHANCEMENT OF MSC IMMUNOMODULATORY PROPERTIES BY TREPROSTINIL |
| ENHANCEMENT OF MSC IMMUNOMODULATORY PROPERTIES BY TREPROSTINIL |